Back to funds

Foresite Capital Management VI LLC

Updated 6 days ago

Managed by Foresite Capital Management Vi Llc • Latest filing Q3 2026

Portfolio value
$566.4M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$330.8M
Q1 2026$460.3M
Q2 2026$642.6M
Q3 2026$566.4M

Top holdings

22 positions as of Q3 2026

View filing
C

CG Oncology, Inc.

Value
$149.5M
Shares
2.11M
% Port
26.41%
K

Korsana Biosciences, Inc.

Value
$45.8M
Shares
1.43M
% Port
8.09%
L

Latigo Biotherapeutics, Inc.

Value
$36.8M
Shares
2.20M
% Port
6.50%
S

Seaport Therapeutics, Inc.

Value
$35.9M
Shares
1.78M
% Port
6.34%
D

Denali Therapeutics Inc.

Value
$33.4M
Shares
1.62M
% Port
5.90%
P

Parabilis Medicines, Inc.

Value
$32.3M
Shares
999.0K
% Port
5.70%
A

ALUMIS INC.

Value
$31.4M
Shares
4.25M
% Port
5.54%
M

AGIOS PHARMACEUTICALS, INC.

Value
$27.5M
Shares
827.1K
% Port
4.86%
V

Verastem, Inc.

Value
$25.3M
Shares
3.15M
% Port
4.47%
G

GH Research PLC

Value
$22.1M
Shares
940.5K
% Port
3.90%
C

Corvus Pharmaceuticals, Inc.

Value
$21.1M
Shares
1.83M
% Port
3.72%
K

Kymera Therapeutics, Inc.

Value
$16.4M
Shares
146.3K
% Port
2.89%
A

ArriVent BioPharma, Inc.

Value
$14.8M
Shares
490.3K
% Port
2.62%
O

Obsidian Therapeutics, Inc.

Value
$12.6M
Shares
916.1K
% Port
2.22%
J

Jade Biosciences, Inc.

Value
$12.5M
Shares
886.7K
% Port
2.20%
H

Hinge Health, Inc.

Value
$10.5M
Shares
108.1K
% Port
1.86%
A

Aura Biosciences, Inc.

Value
$8.4M
Shares
1.33M
% Port
1.48%
B

Beam Therapeutics Inc.

Value
$8.1M
Shares
330.0K
% Port
1.42%
Z

Zura Bio Ltd

Value
$7.3M
Shares
1.76M
% Port
1.29%
N

Minerva Neurosciences, Inc.

Value
$6.7M
Shares
1.99M
% Port
1.17%

Explore